Breakthrough Device Heals Organs and Skin with a Single Touch

Operating theatre

The TNT treatment process starts with a dime-sized silicon chip being placed on the surface of the skin.

Chandan Sen, the director of the Center for Regenerative Medicine and Cell-Based Therapies and co-leader of the study, said he expects the technology will be tested on humans within the next year and that he's now in talks with Walter Reed National Medical Center about human trials, USA Today reported.

Researchers also said that the TNT is not limited on skin cells.

Well, now you don't have to look any farther than Columbus, Ohio, where researchers from the Wexner Medical Center at the Ohio State University have developed a device capable of repairing organs with a single touch. "We have shown that skin is a fertile land where we can grow the elements of any organ that is declining", Dr. Chandan Sen, director of Ohio State's Center for Regenerative Medicine & Cell Based Therapies, said in a press release. In less than a week, the technology generated blood vessels ultimately saving the leg. The findings are published in the journal Nature Nanotechnology.

"This is hard to imagine, but it is achievable, successfully working about 98 per cent of the time". The cargo is delivered by a small electrical charge zapping the device.

In a series of lab tests, the Researchers applied the chip to the injured legs of mice that vascular scans revealed had minimal to no blood flow. "Our technology keeps the cells in the body under immune surveillance, so immune suppression is not necessary", says Sen.

In what is seen as a breakthrough in the field of regenerative medicine, Indian-origin researcher in the USA developed a technology that can fix organs, blood vessels and nerves by a single touch. The first is the nanotechnology-based chip used to deliver treatment cargo to adult cells in the living body. Through this process, the DNA will be converted to the specific building block cells of the damaged body part.

TNT does not require any laboratory-based procedures and may be implemented at the point of care.

"It extends the concept known as gene therapy, and it has been around for quite some time", said study collaborator James Lee. In my lab, we have ongoing research trying to understand the mechanism and do even better.

The researchers are awaiting approval from the FDA to conduct human trials.

Related:

Comments

Latest news

Tesla is raising $1.5B to ramp up Model 3 production
Solar power and battery storage now make up a small percentage of Tesla revenue, but it has high hopes for both. Analysts already are speculating whether Tesla will need to raise more cash before the year is over.

Tainted Eggs Prompt Scare in Europe
About 180 poultry farms in the Netherlands have also been temporarily shut in recent days while investigations are held. It is thought to have been used on chickens in Belgium and could be potentially unsafe to humans.

United States special counsel seeks Flynn documents from White House
Flynn is at the centre of suspicions about a possible involvement of Russian. His work includes lucrative speaking engagements with Russian businesses.

Liverpool rocked by Lallana injury: 'A couple of months out'
Roberto Firmino , Ben Woodburn and Dominic Solanke all found the back of the net for the Reds against Bilbao. Anderson, too, is creative and fashioned 75 chances from the flank last season and assisted nine goals.

Other news